Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
 
  
   
Insider Information:   Langer Robert
Relationship:  
City:   Newton
State:   MA
   
Insider Summary:
  
   
Companies Owned :   12    
Direct Shares   23,234,698    

Indirect Shares

  68,091      
Direct Value   $64,517,299    

Indirect Value

  $0      
Total Shares   23,302,789      
Total Value   $64,517,299      


Momenta Pharmaceuticals Inc
 $49,857,155 Echo Therapeutics Inc
 $121 Invivo Therapeutics Holdings Corporation
 $2,750,442 DNIB Upwind Inc
 $0 Cartesian Therapeutics, Inc
 $9,673,727 Kala Pharmaceuticals, Inc.
 $2,235,854 Moderna, Inc.
 $0 Korro Bio
 $0 Lyra Therapeutics, Inc.
 $0 Sqz Biotechnologies Co
 $0 Seer, Inc.
 $0 Momenta Pharmaceuticals Inc
 $49,857,155 Echo Therapeutics Inc
 $121 Invivo Therapeutics Holdings Corporation
 $2,750,442 DNIB Upwind Inc
 $0 Cartesian Therapeutics, Inc
 $9,673,727 Kala Pharmaceuticals, Inc.
 $2,235,854 Moderna, Inc.
 $0 Korro Bio
 $0 Lyra Therapeutics, Inc.
 $0 Sqz Biotechnologies Co
 $0 Seer, Inc.
 $0
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :

    0   
    0    

     Stock price went up :

    0   
    0    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Momenta Pharmaceuticals Inc MNTA Director 2008-08-08 950,022 0    Premium*  
            Echo Therapeutics Inc ECTE Director 2009-12-11 603,450 2004-05-26 0    Premium*  
            Invivo Therapeutics Holdings Cor... NVIV 10% Owner 2013-06-05 7,433,628 0    Premium*  
            DNIB Upwind Inc BIND Director 2016-08-26 738,424 0    Premium*  
            Cartesian Therapeutics, Inc RNAC 10% Owner 2016-06-21 457,603 0    Premium*  
            Kala Pharmaceuticals, Inc. KALA Director, 10% Owner 2017-07-19 326,402 0    Premium*  
            Moderna, Inc. MRNA Director 2022-04-28 11,467,664 2022-04-28 42,396    Premium*  
            Rubius Therapeutics, Inc. RUBY Director 2019-10-14 0 2019-01-14 0    Premium*  
            Korro Bio KRRO Director 2020-11-17 214,326 2020-11-17 25,695    Premium*  
            Lyra Therapeutics, Inc. LYRA Director 2020-05-05 15,167 0    Premium*  
            Sqz Biotechnologies Co SQZ 10% Owner 2020-10-29 243,987 0    Premium*  
            Seer, Inc. SEER 2024-06-12 784,025 0    Premium*  
* Premium Members only  

Records found :    77         Free Registration Required For Full Results.    Limit: 25

Download
  Page 1 of 4
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

 
3m +/-  
Form
MNTA Momenta Pharmaceuticals I... Director   –       •      –    2004-06-21 3 IO $0.00 $0 D/D 0 939,264 -
NVIV Invivo Therapeutics Holdi... 10% Owner   –       –       •   2010-10-26 3 IO $0.00 $0 D/D 0 8,262,360 -
BIND DNIB Upwind Inc Director   –       •      –    2013-09-19 3 IO $0.00 $0 D/D 0 723,424 -
RNAC Cartesian Therapeutics, I... 10% Owner   –       –       •   2016-06-21 3 IO $0.00 $0 D/D 0 457,603 -
KALA Kala Pharmaceuticals, Inc... Director   –       •       •   2017-07-19 3 IO $0.00 $0 D/D 0 326,402 -
KRRO Korro Bio Director   –       •      –    2019-10-02 3 IO $0.00 $0 I/I 0 25,695 -
KRRO Korro Bio Director   –       •      –    2019-10-02 3 IO $0.00 $0 D/D 0 271,238 -
LYRA Lyra Therapeutics, Inc. Director   –       •      –    2020-04-30 3 IO $0.00 $0 D/D 0 14,499 -
SQZ Sqz Biotechnologies Co 10% Owner   –       –       •   2020-10-29 3 IO $0.00 $0 D/D 0 243,987 -
SEER Seer, Inc. Director   –       •      –    2020-12-03 3 IO $0.00 $0 D/D 0 159,526 -
LYRA Lyra Therapeutics, Inc. Director   –       •      –    2020-05-05 4 A $0.00 $0 D/D 668 15,167 0 -
MRNA Moderna, Inc. Director   •       •      –    2022-04-28 4 OE $0.00 $0 D/D 703 11,467,664 0 -
MNTA Momenta Pharmaceuticals I... Director   –       •      –    2005-03-15 4 GD $0.00 $0 D/D 1,000 975,762 -
NVIV Invivo Therapeutics Holdi... 10% Owner   –       –       •   2013-04-24 4 AS $2.96 $7,405 D/D (2,500) 7,503,878 0 -
NVIV Invivo Therapeutics Holdi... 10% Owner   –       –       •   2013-04-25 4 AS $2.94 $7,360 D/D (2,500) 7,501,378 0 -
NVIV Invivo Therapeutics Holdi... 10% Owner   –       –       •   2013-04-26 4 AS $2.85 $7,127 D/D (2,500) 7,498,878 0 -
NVIV Invivo Therapeutics Holdi... 10% Owner   –       –       •   2013-04-29 4 AS $2.99 $7,485 D/D (2,500) 7,496,378 0 -
NVIV Invivo Therapeutics Holdi... 10% Owner   –       –       •   2013-04-30 4 AS $3.19 $7,985 D/D (2,500) 7,493,878 0 -
NVIV Invivo Therapeutics Holdi... 10% Owner   –       –       •   2013-05-01 4 AS $3.17 $7,920 D/D (2,500) 7,491,378 0 -
NVIV Invivo Therapeutics Holdi... 10% Owner   –       –       •   2013-05-02 4 AS $3.05 $7,625 D/D (2,500) 7,488,878 0 -
NVIV Invivo Therapeutics Holdi... 10% Owner   –       –       •   2013-05-03 4 AS $3.02 $7,551 D/D (2,500) 7,486,378 0 -
NVIV Invivo Therapeutics Holdi... 10% Owner   –       –       •   2013-05-06 4 AS $3.00 $7,510 D/D (2,500) 7,483,878 0 -
NVIV Invivo Therapeutics Holdi... 10% Owner   –       –       •   2013-05-07 4 AS $2.94 $7,338 D/D (2,500) 7,481,378 0 -
NVIV Invivo Therapeutics Holdi... 10% Owner   –       –       •   2013-05-08 4 AS $2.86 $7,145 D/D (2,500) 7,478,878 0 -
NVIV Invivo Therapeutics Holdi... 10% Owner   –       –       •   2013-05-09 4 AS $2.94 $7,338 D/D (2,500) 7,476,378 0 -

  77  Records found
  1  2   3   4      
  Page 1 of 4  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed